Clinical Trials in Massachusetts

Showing 7681-7700 of 17,868 trials

COMPLETED13 miles

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

NCT04855617

This study is designed to determine whether symptom burden differs by time to infusion.

Multiple Sclerosis

NYU Langone Health122 participantsStarted Oct 2020

Wellesley, Massachusetts, United States • New York, New York, United States

COMPLETEDNA14 miles

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

NCT00963040

The objective of this prospective, randomized, double-blind, parallel-group, placebo-controlled study is to determine the effectiveness of intranasal oxytocin in subjects suffering from chronic daily headache.

Chronic Daily Headache

MedVadis Research Corporation60 participantsStarted Nov 2009

Wellesley Hills, Massachusetts, United States

COMPLETEDPhase 314 miles

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00002878

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Some tumors become resistant to chemotherapy drugs. Combining PSC 833 with chemotherapy may reduce resistance to the drug, and allow more tumor cells to be killed. It is not yet known whether combination chemotherapy plus PSC 833 is more effective than combination chemotherapy alone in treating patients with relapsed or refractory multiple myeloma. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without PSC 833 in treating patients with relapsed or refractory multiple myeloma.

Multiple Myeloma and Plasma Cell Neoplasm

Eastern Cooperative Oncology GroupStarted Jun 1997

La Jolla, California, United States • San Francisco, California, United States • Wilmington, Delaware, United States +37 more locations

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Find Trials by Condition in Massachusetts

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Methylphenidate in Treating Patients With Melanoma

Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism

Implementation of Women's Health Patient Aligned Care Teams

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Low Dose IL-2 for Ulcerative Colitis

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Values-Affirmation Intervention Targeting Medication Adherence in Older Adults With Heart Failure

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Study of MT-5111 in HER2-positive Solid Tumors